Time-in-range Using Continuous Glucose Monitoring Management of Gestational Diabetes Mellitus

Completed · Not applicable

Conditions studied: Gestational Diabetes

In brief

The continual glucose is going to increase time-in-range compared to the standard method in women with gestational diabetes

Key facts

Study ID

NCT04605497

Run by

Oregon Health and Science University

People needed

111

Starts

2021-02-11

Expected to finish

2023-12-31

Last updated by the study team

2024-05-31

Who can join

Age: 18 and older, up to 55. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-55 years
• Singleton pregnancy ≥20 weeks gestation
• Diagnosed with GDM by either 1-step (IADPSG) or 2-Step (Carpenter-Coustan)
• Compatible, validated phone and operating system to support Dexcom G6 CGM App (See Supplementary Table 1) or option to use receiver

You may not qualify if…

• Chronic immunosuppression
• Concomitant disease or condition that may compromise patient safety or the ability to complete study tasks including and not limited to: severe mental illness or a diagnosed or suspected eating disorder
• Known allergy to medical grade adhesives
• Pre-gestational diabetes
• Multifetal gestation
• Current alcohol or illicit drug use
• Simultaneous participation in another clinical study with investigational medicinal product(s) that might have an impact on the study objectives.

Where it is running

• OHSU — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.